Stevanato to introduce Vertiva 10mL on-body delivery system platform

Stevanato Group announced the expansion of its Vertiva platform, which will include a 10mL option to be presented at CPHI Milan in October. The Vertiva easy-to-use platform can be pre-programmed to accommodate different motor driven dosing profiles, from micro-precision basal delivery to full-content bolus injections. This flexibility makes the platform ideal for administering a wide range of small molecule and biologic therapies, enabling treatment for conditions such as cardiovascular and metabolic disorders, oncology, immunology, and pain management.